HectorFelipeFernandezMD

PubMed

• Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.
  Perez LE, Fernandez H, Ayala E, Beato F, Neuger A, Pidala J, Schell MJ, Anasetti C> ;Bone Marrow Transplant.. 2016-12-19
• New sources for argument: do HLA-C and HLA disparity in adult double umbilical cord blood transplants predict outcomes?
  Tees MT, Betts B, Hillgruber R, Ayala E, Field T, Kharfan-Dabaja MA, Locke F, Mishra A, Nishihori T, Ochoa-Bayona JL, Perez L, Pidala J, Anasetti C, Fernandez H, Riche...> ;Bone Marrow Transplant.. 2016-09-01
• Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary.
  Watts JM, Wang XV, Swords RT, Paietta E, Douer D, Lugar SM, Fernandez HF, Rowe JM, Lazarus HM, Tallman MS, Litzow MR> ;Bone Marrow Transplant.. 2016-07-01
• Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experie...
  Nelson R, Shapiro JF, Perkins JB, Kim J, Nishihori T, Pidala J, Ayala E, Locke FL, Field T, Mishra A, Riches M, Betts B, Perez L, Yue B, Ochoa-Bayona JL, Alsina M, Fer...> ;Bone Marrow Transplant.. 2015-11-01
• Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission.
  Kunter, G.,Perkins, J. B.,Pidala, J.,Nishihori, T.,Kharfan-Dabaja, M. A.,Field, T.,Fernandez, H.,Perez, L.,Locke, F.,Ayala, E.,Tomblyn, M.,Ochoa-Bayona, J. L.,Betts, B...> ;Bone Marrow Transplant.. 2013 Sep 2
• Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 years.
  Janssen WE, Rahn D, Hackett M, Coyle D, Tomblyn M, Smilee RC, Anasetti C, Fernandez HF> ;Bone Marrow Transplant.. 2012-12-01
• Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.
  Pidala, J., Kim, J., Schell, M., Lee, S. J., Hillgruber, R., Nye, V., Ayala, E., Alsina, M., Betts, B., Bookout, R., Fernandez, H. F., Field, T., Locke, F. L., Nishiho...> ;Bone Marrow Transplant. 2013 Mar
• Pulmonary alveolar proteinosis following allogeneic hematopoietic cell transplantation.
  Pidala J, Khalil F, Fernandez H> ;Bone Marrow Transplant.. 2011-11-01
• Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time ...
  Perkins J, Field T, Kim J, Kharfan-Dabaja MA, Ayala E, Perez L, Fernandez H, Fancher K, Tate C, Shaw LM, Milone MC, Gardiner JA, Miller S, Anasetti C> ;Bone Marrow Transplant.. 2011-11-01
• Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity.
  Pidala J, Kim J, Anasetti C, Kharfan-Dabaja MA, Field T, Perkins J, Ayala E, Perez L, Fernandez H> ;Bone Marrow Transplant.. 2011-05-01
• Sirolimus for treatment of steroid-refractory acute graft-versus-host disease.
  Hoda D, Pidala J, Salgado-Vila N, Kim J, Perkins J, Bookout R, Field T, Perez L, Ayala E, Ochoa-Bayona JL, Raychaudhuri J, Alsina M, Greene J, Janssen W, Fernandez HF,...> ;Bone Marrow Transplant.. 2010-08-01
• Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease.
  Pidala J, Kim J, Perkins J, Field T, Fernandez H, Perez L, Ayala E, Kharfan-Dabaja M, Anasetti C> ;Bone Marrow Transplant.. 2010-05-01
• 5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.
  Field T, Perkins J, Huang Y, Kharfan-Dabaja MA, Alsina M, Ayala E, Fernandez HF, Janssen W, Lancet J, Perez L, Sullivan D, List A, Anasetti C> ;Bone Marrow Transplant.. 2010-02-01
• Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience.
  Escalón MP, Stefanovic A, Venkatraman A, Pereira D, Santos ES, Goodman M, Byrnes JJ, Fernandez HF> ;Bone Marrow Transplant.. 2009-07-01
• Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road?
  Fernandez HF, Escalón MP, Pereira D, Lazarus HM> ;Bone Marrow Transplant.. 2007-09-01
• Acute graft-versus-host disease (aGVHD) presenting with an acquired lupus anticoagulant.
  Kharfan-Dabaja MA, Morgensztern D, Santos E, Goodman M, Fernandez HF> ;Bone Marrow Transplant.. 2003-01-01
• Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy).
  Andersson BS, Gajewski J, Donato M, Giralt S, Gian V, Wingard J, Tarantolo S, Fernandez H, Hu WW, Blume K, Kashyap A, Forman SJ, Champlin RE> ;Bone Marrow Transplant.. 2000-05-01
• Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
  Koya R, Andersen J, Fernandez H, Goodman M, Spector N, Smith R, Hanlon J, Cassileth PA> ;Bone Marrow Transplant.. 1998-05-01
• Join now to see all